118 related articles for article (PubMed ID: 2175221)
1. Turnover of *I-protein C inhibitor and *I-alpha 1-antitrypsin and their complexes with activated protein C.
Laurell M; Stenflo J; Carlson TH
Blood; 1990 Dec; 76(11):2290-5. PubMed ID: 2175221
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
[TBL] [Abstract][Full Text] [Related]
4. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
5. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
6. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
Heeb MJ; Griffin JH
J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
[TBL] [Abstract][Full Text] [Related]
7. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
[TBL] [Abstract][Full Text] [Related]
8. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
9. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
Marlar RA; Kressin DC; Madden RM
Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
11. α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.
Martos L; Ramón LA; Oto J; Fernández-Pardo Á; Bonanad S; Cid AR; Gruber A; Griffin JH; España F; Navarro S; Medina P
Thromb Haemost; 2018 Apr; 118(4):630-638. PubMed ID: 29448296
[TBL] [Abstract][Full Text] [Related]
12. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of plasma protein C inhibitor.
España F; Berrettini M; Griffin JH
Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
[TBL] [Abstract][Full Text] [Related]
14. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's.
España F; Griffin JH
Thromb Res; 1989 Sep; 55(6):671-82. PubMed ID: 2551066
[TBL] [Abstract][Full Text] [Related]
15. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
16. Complexes of activated protein C with alpha 1-antitrypsin in normal pregnancy and in severe preeclampsia.
España F; Gilabert J; Aznar J; Estellés A; Kobayashi T; Griffin JH
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1310-6. PubMed ID: 1852102
[TBL] [Abstract][Full Text] [Related]
17. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin.
Heeb MJ; Gruber A; Griffin JH
J Biol Chem; 1991 Sep; 266(26):17606-12. PubMed ID: 1716632
[TBL] [Abstract][Full Text] [Related]
18. Activation of the protein C pathway in acute sepsis.
Alcaraz A; España F; Sánchez-Cuenca J; Zuazu I; Estellés A; Aznar J; Vicente V
Thromb Res; 1995 Jul; 79(1):83-93. PubMed ID: 7495107
[TBL] [Abstract][Full Text] [Related]
19. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
Radtke KP; Stief TW; Heimburger N
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
[TBL] [Abstract][Full Text] [Related]
20. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
Pratt CW; Church FC; Pizzo SV
Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
